Daniel E. Fürst - Concepedia

Author

Daniel E. Fürst

University of California, Los Angeles ORCID

Also Known As

C. Subang, D E FURST, D E Furst, D Furst, D Fürst, D. E. FURST, D. E. Furst, D. Furst, D.E Furst, D.E. Furst

367

Publications

34.5K

Citations

H-Index

142

Concepts

All Affiliations

University of California, Los Angeles Virginia Mason Medical Center University of Washington Johns Hopkins University University of Michigan

About

Daniel E. Fürst is an author at University of California, Los Angeles specializing in medicine, rheumatology, and rheumatoid arthritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	48	7.2K
2	Health Sciences	5	5	454
3	Education	1	1	24
4	Engineering	1	1	282
5	Nursing	1	1	20

Daniel E. Fürst

171

Publications

28.3K

Citations

H-Index

Page 1

	Year	Citations
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair, New England Journal of Medicine	2000	3K
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis David T. Felson, Jennifer J. Anderson, Maarten Boers, Arthritis & Rheumatism	1995	2.8K
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld, The Lancet InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune Disease	1999	2.3K
The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials David T. Felson, Jennifer J. Anderson, Maarten Boers, Arthritis & Rheumatism	1993	1.6K
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials David T. Felson, Josef S Smolen, George A. Wells, Annals of the Rheumatic Diseases	2011	754
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010 Daniel E. Fürst, Edward Keystone, Jürgen Braun, Annals of the Rheumatic Diseases	2011	691
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT) Christian Antoni, Arthur Kavanaugh, Bruce Kirkham, Arthritis & Rheumatism	2005	636
Methotrexate for Rheumatoid Arthritis Joel M. Kremer, Graciela S. Alarcón, Robert W. Lightfoot, Arthritis & Rheumatism	1994	609
Microchimerism and HLA-compatible relationships of pregnancy in scleroderma J. Lee Nelson, Daniel E. Fürst, Sean Maloney, The Lancet Maternal ImmunizationInfertilitySystemic SclerodermaReproductive HealthGynecology	1998	597
Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events Kenneth G. Saag, Rochelle Koehnke, Jacques R. Caldwell, The American Journal of Medicine Rheumatoid DisorderRheumatologyMedicineRheumatic DiseasesOsteoarthritis	1994	533

Page 1